Westwood Holdings Group’s Meridian Bioscience Inc VIVO Stock Holding History

Westwood Holdings Group’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-15,024	Closed	-$499K	–	623
2022 Q4	$499K	Buy	15,024 +234	+2%	+$7.54K	﹤0.01%	404
2022 Q3	$467K	Buy	+14,790	New	+$479K	0.01%	373

Other funds holding VIVO

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Westwood Holdings Group's VIVO Position: Q1 2023 in Review

Westwood Holdings Group sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 15,024 shares — an estimated $499K sold.

Westwood Holdings Group first reported a position in VIVO in Q3 2022 and held it in 2 quarters. The position peaked at $499K in Q4 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

Westwood Holdings Group reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
Westwood Holdings Group sold 15,024 Meridian Bioscience Inc shares in Q1 2023, an estimated $499K.
Westwood Holdings Group first reported a position in Meridian Bioscience Inc in Q3 2022 and held it in 2 quarters.
Westwood Holdings Group's Meridian Bioscience Inc position peaked at $499K in Q4 2022.
2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Westwood Holdings Group's 13F filing for Q1 2023, filed 12 May 2023.